Cargando…
Metabolic Risk Factors for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease: A Prospective Study
SIMPLE SUMMARY: About 30% of Americans have nonalcoholic fatty liver disease (NAFLD), and some of these individuals may develop hepatocellular carcinoma (HCC), a frequently fatal cancer. A major current challenge is how to identify those NAFLD patients who are likely to progress to HCC. Metabolic co...
Autores principales: | Antwi, Samuel O., Craver, Emily C., Nartey, Yvonne A., Sartorius, Kurt, Patel, Tushar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777437/ https://www.ncbi.nlm.nih.gov/pubmed/36551719 http://dx.doi.org/10.3390/cancers14246234 |
Ejemplares similares
-
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
por: Kikuchi, Luciana, et al.
Publicado: (2014) -
Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
por: Inayat, Faisal, et al.
Publicado: (2016) -
Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
por: Sumida, Yoshio, et al.
Publicado: (2020) -
Abnormal Metabolism in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: Mechanistic Insights to Chemoprevention
por: Orabi, Danny, et al.
Publicado: (2021) -
RNA Therapeutic Options to Manage Aberrant Signaling Pathways in Hepatocellular Carcinoma: Dream or Reality?
por: Sartorius, Kurt, et al.
Publicado: (2022)